02533nam 2200565 450 991078936160332120230803202239.00-309-29665-X0-309-29663-3(CKB)3710000000103204(EBL)3564285(SSID)ssj0001219050(PQKBManifestationID)11702771(PQKBTitleCode)TC0001219050(PQKBWorkID)11212636(PQKB)11569483(MiAaPQ)EBC3564285(Au-PeEL)EBL3564285(CaPaEBR)ebr10863709(OCoLC)932320630(EXLCZ)99371000000010320420140506h20142014 uy 0engurcnu||||||||txtccrOversight and review of clinical gene transfer protocols assessing the role of the recombinant DNA advisory committee /Rebecca N. Lenzi, Bruce M. Altevogt, Lawrence O. Gostin, editors ; Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee : Board on Health Sciences PolicyWashington, District of Columbia :National Academies Press,2014.©20141 online resource (134 p.)Description based upon print version of record.0-309-29662-5 ""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Boxes, Figure, and Tables""; ""Acronyms and Abbreviations""; ""Summary""; ""1 Introduction""; ""2 Gene Transfer Research: The Evolution of the Clinical Science""; ""3 Oversight of Gene Transfer Research""; ""4 Evolution of Oversight of Emerging Clinical Research""; ""Appendix A: Data Sources and Methods""; ""Appendix B: Historical and Policy Timelines for Recombinant DNA Technology""; ""Appendix C: Committee Biographies""GeneticsResearchMoral and ethical aspectsUnited StatesGeneticsResearchHealth aspectsUnited StatesGeneticsResearchMoral and ethical aspectsGeneticsResearchHealth aspects576.5Lenzi Rebecca N.Altevogt Bruce M.Gostin Lawrence O(Lawrence Ogalthorpe),Institute of Medicine (U.S.)MiAaPQMiAaPQMiAaPQBOOK9910789361603321Oversight and review of clinical gene transfer protocols3788878UNINA